The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|8|1|11-14

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.1, 2008-03, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 134-136

Bentham Science Publishers

Access to resources Recommend Favorite

The use of mycophenolate mofetil in liver transplant recipients

By Detry Olivier   de Roover Arnaud   Delwaide Jean   Meurisse Michel   Honoré Pierre  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 1949-1957

Informa Healthcare

Access to resources Recommend Favorite

The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis

By Koukoulaki Maria   Goumenos Dimitrios S  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 673-687

Informa Healthcare

Access to resources Recommend Favorite

Mycophenolate mofetil/tacrolimus: Systemic sarcoidosis in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation

By Young M.   Plosker G.L.  

PharmacoEconomics, Vol. 20, Iss. 10, 2002-01 ,pp. : 675-713

Adis International

Access to resources Recommend Favorite